MedTrace Logo

Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)

NCT02799589 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-04-06

No results posted yet for this study

Summary

This study intends to show the efficacy of remifentanil-dexmedetomidine infusions in combination with a caudal block for patients ages 1 year to 3 years old receiving elective surgery to investigate alternatives to the currently used volatile anesthetics.

Conditions

  • Anesthesia

Interventions

DRUG

Remifentanil

1mcg/kg over 1 min followed by an infusion (0.05-0.5 mcg/kg/min)

DRUG

Dexmedetomidine

1mcg/kg over 10 mins followed by and infusion (0.2-0.7 mcg/kg/hr)

DRUG

Ropivacaine

Caudal anesthesia block with Ropivicaine 0.2% 1ml/kg injected into the caudal space

Sponsors & Collaborators

  • Mofya Diallo

    lead OTHER

Principal Investigators

  • Mofya Diallo, MD · Children's National Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-08-31
Completion
2017-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02799589 on ClinicalTrials.gov